Ascending cholangitis primary prevention

Jump to navigation Jump to search

Ascending cholangitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Ascending cholangitis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Ascending cholangitis primary prevention On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ascending cholangitis primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ascending cholangitis primary prevention

CDC on Ascending cholangitis primary prevention

Ascending cholangitis primary prevention in the news

Blogs on Ascending cholangitis primary prevention

Directions to Hospitals Treating Ascending cholangitis

Risk calculators and risk factors for Ascending cholangitis primary prevention

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anila Hussain, MD [2]

Overview

There are no established measures for the primary prevention of cholangitis in otherwise healthy people

Primary Prevention

There are no established measures for the primary prevention of ascending cholangitis. However, treatment of obstructing factors like gallstones, tumors, and infestations of parasites may reduce the risk for some people. In addition to that, patients undergoing ERCP should have prophylactic antibiotics to prevent biliary infection.[1]. Patients with compromised biliary systems are also prone to developing recurrent cholangitis and may benefit from antibiotic maintenance therapy, given daily in lower-than-therapeutic dosages[2][3][4][5]

References

  1. Sauter G, Ruckdeschel G, Sauerbruch T (1992). "[Antibiotic prevention and therapy of infectious complications in ERCP]". Leber Magen Darm. 22 (5): 173–6. PMID 1406012.
  2. "Ascending cholangitis Prevention - Epocrates Online".
  3. van den Hazel SJ, Speelman P, Tytgat GN, Dankert J, van Leeuwen DJ (1994). "Role of antibiotics in the treatment and prevention of acute and recurrent cholangitis". Clin Infect Dis. 19 (2): 279–86. PMID 7986900.
  4. Lillemoe KD (2000). "Surgical treatment of biliary tract infections". Am Surg. 66 (2): 138–44. PMID 10695743.
  5. Cybulski Z, Solarski J, Majewski W (1994). "[Infection as a risk factor in biliary system surgery]". Wiad Lek. 47 (15–16): 619–24. PMID 7716962.